Unicycive Therapeutics Inc (NASDAQ:UNCY) saw its shares plunge 26% in early trading after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the company’s ...

Unicycive Therapeutics has hit a bump on the road in its mission to bring its hyperphosphatemia treatment candidate to ...

LOS ALTOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. ("Unicycive” or the "Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for ...

We are writing in response to your letter dated April 11, 2025, addressed to Dr. Alan Garber, Harvard's President, and Penny Pritzker, Senior Fellow of the Harvard Corporation.